Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2023 | May 04, 2023 | |
Document Information [Line Items] | ||
Entity Central Index Key | 0001173489 | |
Entity Registrant Name | CEVA INC | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2023 | |
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2023 | |
Document Transition Report | false | |
Entity File Number | 000-49842 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 77-0556376 | |
Entity Address, Address Line One | 15245 Shady Grove Road, Suite 400 | |
Entity Address, City or Town | Rockville | |
Entity Address, State or Province | MD | |
Entity Address, Postal Zip Code | 20850 | |
City Area Code | 240 | |
Local Phone Number | 308-8328 | |
Title of 12(b) Security | Common Stock, $.001 per share | |
Trading Symbol | CEVA | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 23,416,026 |
Interim Condensed Consolidated
Interim Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 24,483 | $ 21,285 |
Short-term bank deposits | 6,164 | 6,114 |
Marketable securities | 106,142 | 112,080 |
Trade receivables (net of allowance for credit losses of $313 as of both March 31, 2023 and December 31, 2022) | 35,007 | 31,250 |
Prepaid expenses and other current assets | 8,766 | 6,896 |
Total current assets | 180,562 | 177,625 |
Long-term assets: | ||
Bank deposits | 8,280 | 8,205 |
Severance pay fund | 8,183 | 8,475 |
Deferred tax assets, net | 9,434 | 8,599 |
Property and equipment, net | 6,696 | 7,099 |
Operating lease right-of-use assets | 10,034 | 10,283 |
Goodwill | 74,777 | 74,777 |
Intangible assets, net | 6,003 | 6,680 |
Investments in marketable equity securities | 291 | 408 |
Other long-term assets | 6,874 | 6,291 |
Total long-term assets | 130,572 | 130,817 |
Total assets | 311,134 | 308,442 |
Current liabilities: | ||
Trade payables | 1,820 | 1,995 |
Deferred revenues | 4,006 | 3,168 |
Accrued expenses and other payables | 7,280 | 6,660 |
Accrued payroll and related benefits | 19,073 | 18,473 |
Operating lease liabilities | 2,858 | 2,982 |
Total current liabilities | 35,037 | 33,278 |
Long-term liabilities: | ||
Accrued severance pay | 9,064 | 9,064 |
Operating lease liabilities | 6,530 | 6,703 |
Other accrued liabilities | 633 | 526 |
Total long-term liabilities | 16,227 | 16,293 |
Stockholders’ equity: | ||
Preferred Stock: $0.001 par value: 5,000,000 shares authorized; none issued and outstanding | 0 | 0 |
Common Stock: $0.001 par value: 45,000,000 shares authorized; 23,595,160 shares issued at March 31, 2023 and December 31, 2022. 23,416,026 and 23,215,439 shares outstanding at March 31, 2023 and December 31, 2022, respectively | 23 | 23 |
Additional paid in-capital | 243,141 | 242,841 |
Treasury stock at cost (179,134 and 379,721 shares of common stock at March 31, 2023, and December 31, 2022, respectively) | (4,672) | (9,904) |
Accumulated other comprehensive loss | (5,910) | (6,249) |
Retained earnings | 27,288 | 32,160 |
Total stockholders’ equity | 259,870 | 258,871 |
Total liabilities and stockholders’ equity | $ 311,134 | $ 308,442 |
Interim Condensed Consolidate_2
Interim Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Allowance for doubtful accounts | $ 313 | $ 313 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 45,000,000 | 45,000,000 |
Common stock, shares issued (in shares) | 23,595,160 | 23,595,160 |
Common stock, shares outstanding (in shares) | 23,416,026 | 23,215,439 |
Treasury Stock, Common, Shares | 179,134 | 379,721 |
Interim Condensed Consolidate_3
Interim Condensed Consolidated Statements of (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Revenues: | ||
Revenues | $ 28,735 | $ 34,391 |
Cost of revenues | 5,315 | 6,404 |
Gross profit | 23,420 | 27,987 |
Operating expenses: | ||
Research and development, net | 20,791 | 20,210 |
Sales and marketing | 3,045 | 2,923 |
General and administrative | 4,048 | 3,636 |
Amortization of intangible assets | 329 | 750 |
Total operating expenses | 28,213 | 27,519 |
Operating income (loss) | (4,793) | 468 |
Financial income, net | 1,455 | 282 |
Remeasurement of marketable equity securities | (117) | (1,131) |
Loss before taxes on income | (3,455) | (381) |
Income tax expense | 1,417 | 1,315 |
Net loss | $ (4,872) | $ (1,696) |
Basic net loss per share (in dollars per share) | $ (0.21) | $ (0.07) |
Diluted net loss per share (in dollars per share) | $ (0.21) | $ (0.07) |
Weighted-average shares used to compute net loss per share (in thousands): | ||
Basic (in shares) | 23,334 | 23,103 |
Diluted (in shares) | 23,334 | 23,103 |
License [Member] | ||
Revenues: | ||
Revenues | $ 20,721 | $ 22,393 |
Royalty [Member] | ||
Revenues: | ||
Revenues | $ 8,014 | $ 11,998 |
Interim Condensed Consolidate_4
Interim Condensed Consolidated Statements of Comprehensive (Loss) (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Net loss | $ (4,872) | $ (1,696) |
Available-for-sale securities: | ||
Changes in unrealized gains (losses) | 730 | (2,839) |
Reclassification adjustments for gains included in net loss | (92) | 0 |
Net change | 638 | (2,839) |
Cash flow hedges: | ||
Derivatives designated as cash flow hedging instruments | (425) | 2 |
Reclassification adjustments for losses included in net loss | 171 | 110 |
Net change | (254) | 112 |
Other comprehensive income (loss) before tax | 384 | (2,727) |
Income tax expense (benefit) related to components of other comprehensive income (loss) | 45 | (661) |
Other comprehensive income (loss), net of taxes | 339 | (2,066) |
Comprehensive loss | $ (4,533) | $ (3,762) |
Interim Condensed Consolidate_5
Interim Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands | Common Stock Outstanding [Member] | Additional Paid-in Capital [Member] | Treasury Stock, Common [Member] | AOCI Attributable to Parent [Member] | Retained Earnings [Member] | Total |
Balance (in shares) at Dec. 31, 2021 | 22,984,552 | |||||
Balance at Dec. 31, 2021 | $ 23 | $ 235,386 | $ (13,790) | $ (372) | $ 55,485 | $ 276,732 |
Net loss | 0 | 0 | 0 | 0 | (1,696) | (1,696) |
Other comprehensive income | 0 | 0 | 0 | (2,066) | 0 | (2,066) |
Equity-based compensation | $ 0 | 3,389 | 0 | 0 | 0 | 3,389 |
Issuance of treasury stock upon exercise of stock-based awards (in shares) | 219,722 | |||||
Issuance of treasury stock upon exercise of stock-based awards | $ 0 | (3,212) | 4,962 | 0 | (30) | 1,720 |
Balance (in shares) at Mar. 31, 2022 | 23,204,274 | |||||
Balance at Mar. 31, 2022 | $ 23 | 235,563 | (8,828) | (2,438) | 53,759 | 278,079 |
Balance (in shares) at Dec. 31, 2022 | 23,215,439 | |||||
Balance at Dec. 31, 2022 | $ 23 | 242,841 | (9,904) | (6,249) | 32,160 | 258,871 |
Net loss | 0 | 0 | 0 | 0 | (4,872) | (4,872) |
Other comprehensive income | 0 | 0 | 0 | 339 | 0 | 339 |
Equity-based compensation | $ 0 | 3,859 | 0 | 0 | 0 | 3,859 |
Issuance of treasury stock upon exercise of stock-based awards (in shares) | 200,587 | |||||
Issuance of treasury stock upon exercise of stock-based awards | $ 0 | (3,559) | 5,232 | 0 | 0 | 1,673 |
Balance (in shares) at Mar. 31, 2023 | 23,416,026 | |||||
Balance at Mar. 31, 2023 | $ 23 | $ 243,141 | $ (4,672) | $ (5,910) | $ 27,288 | $ 259,870 |
Interim Condensed Consolidate_6
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cash flows from operating activities: | ||
Net loss | $ (4,872) | $ (1,696) |
Adjustments required to reconcile net loss to net cash provided by (used in) operating activities: | ||
Depreciation | 742 | 780 |
Amortization of intangible assets | 677 | 1,167 |
Equity-based compensation | 3,859 | 3,389 |
Realized gain on sale of available-for-sale marketable securities | (92) | 0 |
Amortization of premiums on available-for-sale marketable securities | 23 | 123 |
Unrealized foreign exchange (gain) loss | (285) | 154 |
Remeasurement of marketable equity securities | 117 | 1,131 |
Changes in operating assets and liabilities: | ||
Trade receivables | (3,802) | 3,944 |
Prepaid expenses and other assets | (2,205) | (3,034) |
Operating lease right-of-use assets | 249 | 425 |
Accrued interest on bank deposits | (125) | (9) |
Deferred tax, net | (880) | (991) |
Trade payables | (412) | 736 |
Deferred revenues | 838 | 70 |
Accrued expenses and other payables | 357 | 92 |
Accrued payroll and related benefits | 702 | 3,710 |
Operating lease liability | (275) | (454) |
Accrued severance pay, net | 308 | 287 |
Net cash provided by (used in) operating activities | (5,076) | 9,824 |
Cash flows from investing activities: | ||
Purchase of property and equipment | (105) | (909) |
Proceeds from bank deposits | 0 | 1,385 |
Investment in available-for-sale marketable securities | 0 | (8,789) |
Proceeds from maturity of available-for-sale marketable securities | 1,750 | 3,500 |
Proceeds from sale of available-for-sale marketable securities | 4,895 | 0 |
Net cash provided by (used in) investing activities | 6,540 | (4,813) |
Cash flows from financing activities: | ||
Proceeds from exercise of stock-based awards | 1,673 | 1,720 |
Net cash provided by financing activities | 1,673 | 1,720 |
Effect of exchange rate changes on cash and cash equivalents | 61 | (106) |
Increase in cash and cash equivalents | 3,198 | 6,625 |
Cash and cash equivalents at the beginning of the period | 21,285 | 33,153 |
Cash and cash equivalents at the end of the period | 24,483 | 39,778 |
Supplemental information of cash-flow activities: | ||
Income and withholding taxes | 1,860 | 2,355 |
Non-cash transactions: | ||
Property and equipment purchases incurred but unpaid at period end | 234 | 948 |
Right-of-use assets obtained in the exchange for operating lease liabilities | $ 506 | $ 308 |
Note 1 - Business
Note 1 - Business | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Nature of Operations [Text Block] | NOTE 1: BUSINESS The financial information in this quarterly report includes the results of CEVA, Inc. and its subsidiaries (the “Company” or “CEVA”). CEVA licenses a family of wireless connectivity and smart sensing technologies and is a provider of chip design services. The Company’s offerings include Digital Signal Processors (“DSPs”), AI processors, short and long range connectivity solutions, 5G 5G 4D 4/5/6/6E 802.11n/ac/ax CEVA’s Intrinsix business also expands its market reach to the aerospace and defense markets and allows it to offer co-creation solutions that combine CEVA’s standardized, off-the-shelf IP together with Intrinsix’s NRE design capabilities and IP in RF, mixed-signal, security, high complexity digital design, chiplets and more. CEVA’s technologies are licensed to leading semiconductor and Original Equipment Manufacturer (“OEM”) companies. These companies design, manufacture, market and sell Application-Specific Integrated Circuits (“ASICs”) and Application-Specific Standard Products (“ASSPs”) based on CEVA’s technology to mobile, consumer, automotive, robotics, industrial, aerospace & defense and IoT companies for incorporation into a wide variety of end products. |
Note 2 - Basis of Presentation
Note 2 - Basis of Presentation and Summary Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] | NOTE 2: BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”). The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three March 31, 2023, not may December 31, 2023. 10 December 31, 2022. The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, 10 March 1, 2023, Accounting Standards Recently Issued, Not In June 2022, No. 2022 03, 820 820. December 15, 2023, not Use of Estimates The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Note 3 - Revenue Recognition
Note 3 - Revenue Recognition | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Revenue from Contract with Customer [Text Block] | NOTE 3: REVENUE RECOGNITION Under Accounting Standards Codification ("ASC") 606, 606” 606 The following table includes estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The estimated revenues do not Remainder of 202 3 202 4 202 5 202 6 Licensing, NRE and related revenues $ 10,083 $ 906 $ 519 $ 96 Disaggregation of revenue: The following table provides information about disaggregated revenue by primary geographical market, major product line and timing of revenue recognition: Three months ended March 31, 2023 (unaudited) Three months ended March 31, 2022 (unaudited) Licensing, NRE and related revenues Royalties Total Licensing, NRE and related revenues Royalties Total Primary geographical markets United States $ 2,791 $ 1,650 $ 4,441 $ 4,475 $ 2,271 $ 6,746 Europe and Middle East 2,334 859 3,193 437 665 1,102 Asia Pacific 15,121 5,505 20,626 17,481 9,062 26,543 Other 475 — 475 — — — Total $ 20,721 $ 8,014 $ 28,735 $ 22,393 $ 11,998 $ 34,391 Major product/service lines Connectivity products (baseband for handset and other devices, Bluetooth, Wi-Fi, NB-IoT and SATA/SAS) $ 16,532 $ 5,665 $ 22,197 $ 16,815 $ 9,062 $ 25,877 Smart sensing products (AI, sensor fusion, audio/sound and imaging and vision) 4,189 2,349 6,538 5,578 2,936 8,514 Total $ 20,721 $ 8,014 $ 28,735 $ 22,393 $ 11,998 $ 34,391 Timing of revenue recognition Products transferred at a point in time $ 14,621 $ 8,014 $ 22,635 $ 15,932 $ 11,998 $ 27,930 Products and services transferred over time 6,100 — 6,100 6,461 — 6,461 Total $ 20,721 $ 8,014 $ 28,735 $ 22,393 $ 11,998 $ 34,391 Contract balances: The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers: March 31, 2023 (unaudited) December 31, 2022 Trade receivables $ 17,430 $ 12,297 Unbilled receivables (associated with licensing, NRE and related revenue) 9,731 8,695 Unbilled receivables (associated with royalties) 7,846 10,258 Deferred revenues (short-term contract liabilities) 4,006 3,168 The Company receives payments from customers based upon contractual payment schedules; trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables associated with licensing, NRE and other include amounts related to the Company’s contractual right to consideration for completed performance objectives not not During the three March 31, 2023, January 1, 2023. |
Note 4 - Leases
Note 4 - Leases | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Lessee, Operating Leases [Text Block] | NOTE 4: LEASES The Company leases substantially all of its office space and vehicles under operating leases. The Company's leases have original lease periods expiring between 2023 2034. one not not The following is a summary of weighted average remaining lease terms and discount rates for all of the Company’s operating leases: March 31, 2023 (Unaudited) Weighted average remaining lease term (years) 4.85 Weighted average discount rates 3.51 % Total operating lease cost and cash payments for operating leases were as follows: Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Operating lease cost $ 822 $ 800 Cash payments for operating leases $ 819 $ 830 Maturities of lease liabilities are as follows: The remainder of 2023 $ 2,257 2024 2,589 2025 1,979 2026 970 2027 962 2028 and thereafter 1,361 Total undiscounted cash flows 10,118 Less imputed interest 730 Present value of lease liabilities $ 9,388 |
Note 5 - Marketable Securities
Note 5 - Marketable Securities | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Cash, Cash Equivalents, and Marketable Securities [Text Block] | NOTE 5: MARKETABLE SECURITIES The following is a summary of available-for-sale marketable securities: March 31, 2023 (Unaudited) Amortized cost Gross unrealized gains Gross unrealized losses Fair value Available-for-sale - matures within one year: Corporate bonds $ 23,397 $ — $ (1,517 ) $ 21,880 Available-for-sale - matures after one year through four years: Corporate bonds 88,934 25 (4,697 ) 84,262 Total $ 112,331 $ 25 $ (6,214 ) $ 106,142 December 31, 2022 Amortized cost Gross unrealized gains Gross unrealized losses Fair value Available-for-sale - matures within one year: Corporate bonds $ 17,552 $ — $ (1,330 ) $ 16,222 Available-for-sale - matures after one year through five years: Corporate bonds 101,355 38 (5,535 ) 95,858 Total $ 118,907 $ 38 $ (6,865 ) $ 112,080 The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March 31, 2023, December 31, 2022, Less than 12 months 12 months or greater Fair value Gross unrealized loss Fair value Gross unrealized loss As of March 31, 2023 (unaudited) $ 36,115 $ (877 ) $ 64,211 $ (5,337 ) As of December 31, 2022 $ 58,706 $ (1,885 ) $ 48,539 $ (4,980 ) As of March 31, 2023, not The following table presents gross realized gains and losses from sale of available-for-sale marketable securities: Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Gross realized gains from sale of available-for-sale marketable securities $ 92 $ — Gross realized losses from sale of available-for-sale marketable securities $ — $ — |
Note 6 - Fair Value Measurement
Note 6 - Fair Value Measurement | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Fair Value Disclosures [Text Block] | NOTE 6: FAIR VALUE MEASUREMENT FASB ASC No. 820, three Level I Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities; Level II Quoted prices in markets that are not Level III Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no The Company measures its marketable securities, investments in marketable equity securities and foreign currency derivative contracts at fair value. The carrying amount of cash, cash equivalents, short-term bank deposits, trade receivables, other accounts receivable, trade payables and other accounts payables approximate fair value due to the short-term maturity of these instruments. Investments in marketable equity securities are classified within Level I as the securities are traded in an active market. Marketable securities and foreign currency derivative contracts are classified within Level II as the valuation inputs are based on quoted prices and market observable data of similar instruments. The table below sets forth the Company’s assets and liabilities measured at fair value by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Description March 31, 2023 (unaudited) Level I (unaudited) Level II (unaudited) Level III (unaudited) Assets: Marketable securities: Corporate bonds $ 106,142 — $ 106,142 $ — Investments in marketable equity securities 291 291 — — Liabilities Foreign exchange contracts 360 — 360 — Description December 31, 2022 Level I Level II Level III Assets: Marketable securities: Corporate bonds $ 112,080 — $ 112,080 — Foreign exchange contracts 13 — 13 — Investments in marketable equity securities 408 408 — — Liabilities Foreign exchange contracts 119 — 119 — |
Note 7 - Intangible Assets, Net
Note 7 - Intangible Assets, Net | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Intangible Assets Disclosure [Text Block] | NOTE 7: INTANGIBLE ASSETS, NET March 31, 2023 (unaudited) December 31, 2022 Weighted average amortization p eriod (years) Gross carrying amount Accumulated amortization Impairment (*) Net Gross carrying amount Accumulated amortization Impairment (*) Net Intangible assets –amortizable: Intangible assets related to the acquisition of Intrinsix business Customer relationships 5.5 $ 3,604 $ 1,201 $ — $ 2,403 $ 3,604 $ 1,037 $ — $ 2,567 Customer backlog 1.5 421 421 — — 421 421 — — Patents 5.0 218 80 — 138 218 69 — 149 Core technologies 3.0 3,329 2,035 — 1,294 3,329 1,757 — 1,572 Intangible assets related to the acquisition of Hillcrest Labs business Customer relationships 4.4 $ 3,518 $ 3,070 $ — $ 448 $ 3,518 $ 2,998 $ — $ 520 Customer backlog 0.5 72 72 — — 72 72 — — R&D Tools 7.5 2,475 1,222 — 1,253 2,475 1,140 — 1,335 Intangible assets related to Immervision assets acquisition R&D Tools 6.4 $ 7,063 $ 3,507 $ 3,556 $ — $ 7,063 $ 3,507 $ 3,556 $ — Intangible assets related to an investment in NB-IoT technologies NB-IoT technologies (**) 7.0 $ 1,961 $ 1,494 $ — $ 467 $ 1,961 $ 1,424 $ — $ 537 Total intangible assets $ 22,661 $ 13,102 $ 3,556 $ 6,003 $ 22,661 $ 12,425 $ 3,556 $ 6,680 (*) During 2022, August 2019, (**) During the first 2018, not 2022. not March 31, 2023. 2019 Future estimated annual amortization charges are as follows: Reminder of 2023 1,934 2024 1,909 2025 1,189 2026 956 2027 15 $ 6,003 |
Note 8 - Geographic Information
Note 8 - Geographic Information and Major Customer Data | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Segment Reporting Disclosure [Text Block] | NOTE 8: GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA a. Summary information about geographic areas: The Company manages its business on the basis of one reportable segment: the licensing of intellectual property and co-creation solutions to semiconductor companies and electronic equipment manufacturers (see Note 1 Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Revenues based on customer location: United States $ 4,441 $ 6,746 Europe and Middle East 3,193 1,102 Asia Pacific (1) 20,626 26,543 Other 475 — $ 28,735 $ 34,391 (1) China $ 17,763 $ 22,971 b. Major customer data as a percentage of total revenues: The following table sets forth the customers that represented 10% Three months ended March 31, 2023 2022 (unaudited) (unaudited) Customer A 13 % — Customer B * ) 12 % Customer C * ) 11 % *) Less than 10% |
Note 9 - Net Loss Per Share of
Note 9 - Net Loss Per Share of Common Stock | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Earnings Per Share [Text Block] | NOTE 9: NET LOSS PER SHARE OF COMMON STOCK Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC No. 260, Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Numerator: Net loss $ (4,872 ) $ (1,696 ) Denominator (in thousands): Basic weighted-average common stock outstanding 23,334 23,103 Effect of stock -based awards — — Diluted weighted average common stock outstanding 23,334 23,103 Basic net loss per share $ (0.21 ) $ (0.07 ) Diluted net loss per share $ (0.21 ) $ (0.07 ) The total number of potential shares excluded from the calculation of diluted net loss per share due to their antidilutive effect was 1,181,119 and 853,258 for the three March 31, 2023 2022, |
Note 10 - Common Stock and Stoc
Note 10 - Common Stock and Stock-based Compensation Plans | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Share-Based Payment Arrangement [Text Block] | NOTE 10: COMMON STOCK AND STOCK-BASED COMPENSATION PLANS The Company has historically granted a mix of stock options, stock appreciation rights (“SARs”) capped with a ceiling and restricted stock units (“RSUs”) to employees and non‑employee directors of the Company and its subsidiaries under the Company’s equity plans and provides the right to purchase common stock pursuant to the Company’s 2002 March 31, 2023, December 31, 2022, A summary of the Company’s stock option activities and related information for the three March 31, 2023, Number of options (1) Weighted average exercise price Weighted average remaining contractual term Aggregate intrinsic value Outstanding as of December 31, 2022 106,000 $ 20.24 2.0 $ 609 Granted — — Exercised — — Forfeited or expired — — Outstanding as of March 31, 2023 106,000 $ 20.24 1.8 $ 1,080 Exercisable as of March 31, 2023 106,000 $ 20.24 1.8 $ 1,080 ( 1 Represent options granted to non-employee directors of the Company only. As of March 31, 2023, December 31, 2022, no As of March 31, 2023, no An RSU award is an agreement to issue shares of the Company’s common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest in three first 2017, first 2018, two first On November 9, 2022, January 1, 2023. On November 9, 2022, January 1, 2023. January 1, 2023, 2011 “2011 three first On December 7, 2022, January 1, 2023. January 1, 2023, 2011 three first On February 14, 2023, February 17, 2023, 2011 5635 4 2011 February 17, 2024, February 17, 2025 February 17, 2026. Also, on February 14, 2023, February 17, 2023, 2011 Weighting Goals 50% Vesting of the full 50% of the PSUs occurs if the Company achieves the 2023 “2023 2023 2023 90% 2023 100% 2023 2023 25% Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2023 2023 25% Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2023 2000 2023 Accordingly, assuming maximum achievement of the performance goals set forth above, PSUs representing an additional 30%, meaning an additional 6,543, would be eligible for vesting of the Company’s CEO, and an additional 20%, meaning an additional 1,332, 1,090 and 727, would be eligible for vesting for each of the Company’s CFO, COO and CCO, respectively. Subject to achievement of the thresholds the above performance goals for 2023, February 17, 2024, February 17, 2025 February 17, 2026. Also, on February 14, 2023, February 17, 2023, 2011 first ● if the Company’s compound annual growth rate for non-GAAP Earnings Per Share (“EPS”) for each fiscal year over the three 2022 2025 January 1, 2023 December 31, 2025; ● If the Company’s non-GAAP operating margin for any fiscal year reaches 20% during the period between January 1, 2023 December 31, 2025; ● If the Company’s compound annual growth rate for revenue for each fiscal year over the three 2022 2025 January 1, 2023 December 31, 2025; ● If the Company’s market capitalization (defined as total outstanding shares as of a given date multiplied by the closing price for the Company’s common stock as quoted by the NASDAQ Stock Market) reaches at least $1.1 billion for at least 30 A summary of the Company’s RSU and PSU activities and related information for the three March 31, 2023, Number of RSUs and PSUs Weighted Average Grant-Date Fair Value Unvested as of December 31, 2022 879,277 $ 37.57 Granted 389,560 23.56 Vested (141,165 ) 40.02 Forfeited or expired (52,553 ) 34.58 Unvested as of March 31, 2023 (unaudited) 1,075,119 $ 32.32 As of March 31, 2023, 1.5 The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of income (loss): Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Cost of revenue $ 404 $ 339 Research and development, net 2,173 1,995 Sales and marketing 393 333 General and administrative 889 722 Total equity-based compensation expense $ 3,859 $ 3,389 The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions: Three months ended March 31 2023 (unaudited) 2022 (unaudited) Expected dividend yield 0 % 0 % Expected volatility 45 % 38 % Risk-free interest rate 4.8 % 0.5 % Contractual term of (months) 6 6 |
Note 11 - Derivatives and Hedgi
Note 11 - Derivatives and Hedging Activities | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Derivative Instruments and Hedging Activities Disclosure [Text Block] | NOTE 11: DERIVATIVES AND HEDGING ACTIVITIES The Company follows the requirements of FASB ASC No. 815,” one twelve For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of March 31, 2023, December 31, 2022, The fair value of the Company’s outstanding derivative instruments is as follows: March 31, 2023 (unaudited) December 31, 2022 Derivative assets: Derivatives designated as cash flow hedging instruments: Foreign exchange forward contracts $ — $ 13 Total $ — $ 13 Derivative liabilities: Derivatives designated as cash flow hedging instruments: Foreign exchange option contracts $ 128 $ 23 Foreign exchange forward contracts 232 96 Total $ 360 $ 119 The increase (decrease) in unrealized gains (losses) recognized in “accumulated other comprehensive gain (loss)” on derivatives, before tax effect, is as follows: Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Derivatives designated as cash flow hedging instruments: Foreign exchange option contracts $ (105 ) $ — Foreign exchange forward contracts (320 ) 2 $ (425 ) $ 2 The net (gains) losses reclassified from “accumulated other comprehensive gain (loss)” into income are as follows: Three months ended March 31 2023 (unaudited) 2022 (unaudited) Derivatives designated as cash flow hedging instruments: Foreign exchange option contracts $ — $ — Foreign exchange forward contracts 171 110 $ 171 $ 110 The Company recorded in cost of revenues and operating expenses a net loss of $171 and $110 during the three March 31, 2023 2022, |
Note 12 - Accumulated Other Com
Note 12 - Accumulated Other Comprehensive Income (Loss) | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Comprehensive Income (Loss) Note [Text Block] | NOTE 12: ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) The following tables summarize the changes in accumulated balances of other comprehensive income (loss), net of taxes: Three months ended March 31, 2023 (unaudited) Three months ended March 31, 2022 (unaudited) Unrealized gains (losses) on available-for-sale marketable securities Unrealized gains (losses) on cash flow hedges Total Unrealized gains (losses) on available-for-sale marketable securities Unrealized gains (losses) on cash flow hedges Total Beginning balance $ (6,142 ) $ (107 ) $ (6,249 ) $ (427 ) $ 55 $ (372 ) Other comprehensive income (loss) before reclassifications 684 (426 ) 258 (2,167 ) 4 (2,163 ) Amounts reclassified from accumulated other comprehensive income (loss) (92 ) 173 81 — 97 97 Net current period other comprehensive income (loss) 592 (253 ) 339 (2,167 ) 101 (2,066 ) Ending balance $ (5,550 ) $ (360 ) $ (5,910 ) $ (2,594 ) $ 156 $ (2,438 ) The following table provides details about reclassifications out of accumulated other comprehensive income (loss): Details about Accumulated Other Comprehensive Income (Loss) Components Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Affected Line Item in the Statements of Income (Loss) Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Unrealized losses on cash flow hedges $ (4 ) $ (2 ) Cost of revenues (147 ) (96 ) Research and development (4 ) (3 ) Sales and marketing (16 ) (9 ) General and administrative (171 ) (110 ) Total, before income taxes 2 (13 ) Income tax expense (benefit) (173 ) (97 ) Total, net of income taxes Unrealized gains on available-for-sale marketable securities 92 — Financial income (loss), net — — Income tax expense (benefit) 92 — Total, net of income taxes $ (81 ) $ (97 ) Total, net of income taxes |
Note 13 - Share Repurchase Prog
Note 13 - Share Repurchase Program | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Treasury Stock [Text Block] | NOTE 13: SHARE REPURCHASE PROGRAM The Company did not first 2023 2022. March 31, 2023, The repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders’ equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with FASB ASC No. 505 30, |
Note 14 - Subsequent Event
Note 14 - Subsequent Event | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | NOTE 14: SUBSEQUENT EVENTS In May 2023, 3D two 12 not 10 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”). The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three March 31, 2023, not may December 31, 2023. 10 December 31, 2022. The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, 10 March 1, 2023, |
New Accounting Pronouncements, Policy [Policy Text Block] | Accounting Standards Recently Issued, Not In June 2022, No. 2022 03, 820 820. December 15, 2023, not |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Note 3 - Revenue Recognition (T
Note 3 - Revenue Recognition (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] | Remainder of 202 3 202 4 202 5 202 6 Licensing, NRE and related revenues $ 10,083 $ 906 $ 519 $ 96 |
Disaggregation of Revenue [Table Text Block] | Three months ended March 31, 2023 (unaudited) Three months ended March 31, 2022 (unaudited) Licensing, NRE and related revenues Royalties Total Licensing, NRE and related revenues Royalties Total Primary geographical markets United States $ 2,791 $ 1,650 $ 4,441 $ 4,475 $ 2,271 $ 6,746 Europe and Middle East 2,334 859 3,193 437 665 1,102 Asia Pacific 15,121 5,505 20,626 17,481 9,062 26,543 Other 475 — 475 — — — Total $ 20,721 $ 8,014 $ 28,735 $ 22,393 $ 11,998 $ 34,391 Major product/service lines Connectivity products (baseband for handset and other devices, Bluetooth, Wi-Fi, NB-IoT and SATA/SAS) $ 16,532 $ 5,665 $ 22,197 $ 16,815 $ 9,062 $ 25,877 Smart sensing products (AI, sensor fusion, audio/sound and imaging and vision) 4,189 2,349 6,538 5,578 2,936 8,514 Total $ 20,721 $ 8,014 $ 28,735 $ 22,393 $ 11,998 $ 34,391 Timing of revenue recognition Products transferred at a point in time $ 14,621 $ 8,014 $ 22,635 $ 15,932 $ 11,998 $ 27,930 Products and services transferred over time 6,100 — 6,100 6,461 — 6,461 Total $ 20,721 $ 8,014 $ 28,735 $ 22,393 $ 11,998 $ 34,391 |
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] | March 31, 2023 (unaudited) December 31, 2022 Trade receivables $ 17,430 $ 12,297 Unbilled receivables (associated with licensing, NRE and related revenue) 9,731 8,695 Unbilled receivables (associated with royalties) 7,846 10,258 Deferred revenues (short-term contract liabilities) 4,006 3,168 |
Note 4 - Leases (Tables)
Note 4 - Leases (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Lease, Cost [Table Text Block] | March 31, 2023 (Unaudited) Weighted average remaining lease term (years) 4.85 Weighted average discount rates 3.51 % Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Operating lease cost $ 822 $ 800 Cash payments for operating leases $ 819 $ 830 |
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] | The remainder of 2023 $ 2,257 2024 2,589 2025 1,979 2026 970 2027 962 2028 and thereafter 1,361 Total undiscounted cash flows 10,118 Less imputed interest 730 Present value of lease liabilities $ 9,388 |
Note 5 - Marketable Securities
Note 5 - Marketable Securities (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] | March 31, 2023 (Unaudited) Amortized cost Gross unrealized gains Gross unrealized losses Fair value Available-for-sale - matures within one year: Corporate bonds $ 23,397 $ — $ (1,517 ) $ 21,880 Available-for-sale - matures after one year through four years: Corporate bonds 88,934 25 (4,697 ) 84,262 Total $ 112,331 $ 25 $ (6,214 ) $ 106,142 December 31, 2022 Amortized cost Gross unrealized gains Gross unrealized losses Fair value Available-for-sale - matures within one year: Corporate bonds $ 17,552 $ — $ (1,330 ) $ 16,222 Available-for-sale - matures after one year through five years: Corporate bonds 101,355 38 (5,535 ) 95,858 Total $ 118,907 $ 38 $ (6,865 ) $ 112,080 |
Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] | Less than 12 months 12 months or greater Fair value Gross unrealized loss Fair value Gross unrealized loss As of March 31, 2023 (unaudited) $ 36,115 $ (877 ) $ 64,211 $ (5,337 ) As of December 31, 2022 $ 58,706 $ (1,885 ) $ 48,539 $ (4,980 ) |
Schedule of Realized Gain (Loss) [Table Text Block] | Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Gross realized gains from sale of available-for-sale marketable securities $ 92 $ — Gross realized losses from sale of available-for-sale marketable securities $ — $ — |
Note 6 - Fair Value Measureme_2
Note 6 - Fair Value Measurement (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | Description March 31, 2023 (unaudited) Level I (unaudited) Level II (unaudited) Level III (unaudited) Assets: Marketable securities: Corporate bonds $ 106,142 — $ 106,142 $ — Investments in marketable equity securities 291 291 — — Liabilities Foreign exchange contracts 360 — 360 — Description December 31, 2022 Level I Level II Level III Assets: Marketable securities: Corporate bonds $ 112,080 — $ 112,080 — Foreign exchange contracts 13 — 13 — Investments in marketable equity securities 408 408 — — Liabilities Foreign exchange contracts 119 — 119 — |
Note 7 - Intangible Assets, N_2
Note 7 - Intangible Assets, Net (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Schedule of Finite-Lived Intangible Assets [Table Text Block] | March 31, 2023 (unaudited) December 31, 2022 Weighted average amortization p eriod (years) Gross carrying amount Accumulated amortization Impairment (*) Net Gross carrying amount Accumulated amortization Impairment (*) Net Intangible assets –amortizable: Intangible assets related to the acquisition of Intrinsix business Customer relationships 5.5 $ 3,604 $ 1,201 $ — $ 2,403 $ 3,604 $ 1,037 $ — $ 2,567 Customer backlog 1.5 421 421 — — 421 421 — — Patents 5.0 218 80 — 138 218 69 — 149 Core technologies 3.0 3,329 2,035 — 1,294 3,329 1,757 — 1,572 Intangible assets related to the acquisition of Hillcrest Labs business Customer relationships 4.4 $ 3,518 $ 3,070 $ — $ 448 $ 3,518 $ 2,998 $ — $ 520 Customer backlog 0.5 72 72 — — 72 72 — — R&D Tools 7.5 2,475 1,222 — 1,253 2,475 1,140 — 1,335 Intangible assets related to Immervision assets acquisition R&D Tools 6.4 $ 7,063 $ 3,507 $ 3,556 $ — $ 7,063 $ 3,507 $ 3,556 $ — Intangible assets related to an investment in NB-IoT technologies NB-IoT technologies (**) 7.0 $ 1,961 $ 1,494 $ — $ 467 $ 1,961 $ 1,424 $ — $ 537 Total intangible assets $ 22,661 $ 13,102 $ 3,556 $ 6,003 $ 22,661 $ 12,425 $ 3,556 $ 6,680 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | Reminder of 2023 1,934 2024 1,909 2025 1,189 2026 956 2027 15 $ 6,003 |
Note 8 - Geographic Informati_2
Note 8 - Geographic Information and Major Customer Data (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Revenue from External Customers by Geographic Areas [Table Text Block] | Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Revenues based on customer location: United States $ 4,441 $ 6,746 Europe and Middle East 3,193 1,102 Asia Pacific (1) 20,626 26,543 Other 475 — $ 28,735 $ 34,391 (1) China $ 17,763 $ 22,971 |
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | Three months ended March 31, 2023 2022 (unaudited) (unaudited) Customer A 13 % — Customer B * ) 12 % Customer C * ) 11 % |
Note 9 - Net Loss Per Share o_2
Note 9 - Net Loss Per Share of Common Stock (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Numerator: Net loss $ (4,872 ) $ (1,696 ) Denominator (in thousands): Basic weighted-average common stock outstanding 23,334 23,103 Effect of stock -based awards — — Diluted weighted average common stock outstanding 23,334 23,103 Basic net loss per share $ (0.21 ) $ (0.07 ) Diluted net loss per share $ (0.21 ) $ (0.07 ) |
Note 10 - Common Stock and St_2
Note 10 - Common Stock and Stock-based Compensation Plans (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Share-Based Payment Arrangement, Option, Activity [Table Text Block] | Number of options (1) Weighted average exercise price Weighted average remaining contractual term Aggregate intrinsic value Outstanding as of December 31, 2022 106,000 $ 20.24 2.0 $ 609 Granted — — Exercised — — Forfeited or expired — — Outstanding as of March 31, 2023 106,000 $ 20.24 1.8 $ 1,080 Exercisable as of March 31, 2023 106,000 $ 20.24 1.8 $ 1,080 |
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] | Number of RSUs and PSUs Weighted Average Grant-Date Fair Value Unvested as of December 31, 2022 879,277 $ 37.57 Granted 389,560 23.56 Vested (141,165 ) 40.02 Forfeited or expired (52,553 ) 34.58 Unvested as of March 31, 2023 (unaudited) 1,075,119 $ 32.32 |
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] | Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Cost of revenue $ 404 $ 339 Research and development, net 2,173 1,995 Sales and marketing 393 333 General and administrative 889 722 Total equity-based compensation expense $ 3,859 $ 3,389 |
Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] | Three months ended March 31 2023 (unaudited) 2022 (unaudited) Expected dividend yield 0 % 0 % Expected volatility 45 % 38 % Risk-free interest rate 4.8 % 0.5 % Contractual term of (months) 6 6 |
Note 11 - Derivatives and Hed_2
Note 11 - Derivatives and Hedging Activities (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] | March 31, 2023 (unaudited) December 31, 2022 Derivative assets: Derivatives designated as cash flow hedging instruments: Foreign exchange forward contracts $ — $ 13 Total $ — $ 13 Derivative liabilities: Derivatives designated as cash flow hedging instruments: Foreign exchange option contracts $ 128 $ 23 Foreign exchange forward contracts 232 96 Total $ 360 $ 119 Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Derivatives designated as cash flow hedging instruments: Foreign exchange option contracts $ (105 ) $ — Foreign exchange forward contracts (320 ) 2 $ (425 ) $ 2 |
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Three months ended March 31 2023 (unaudited) 2022 (unaudited) Derivatives designated as cash flow hedging instruments: Foreign exchange option contracts $ — $ — Foreign exchange forward contracts 171 110 $ 171 $ 110 |
Note 12 - Accumulated Other C_2
Note 12 - Accumulated Other Comprehensive Income (Loss) (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | Three months ended March 31, 2023 (unaudited) Three months ended March 31, 2022 (unaudited) Unrealized gains (losses) on available-for-sale marketable securities Unrealized gains (losses) on cash flow hedges Total Unrealized gains (losses) on available-for-sale marketable securities Unrealized gains (losses) on cash flow hedges Total Beginning balance $ (6,142 ) $ (107 ) $ (6,249 ) $ (427 ) $ 55 $ (372 ) Other comprehensive income (loss) before reclassifications 684 (426 ) 258 (2,167 ) 4 (2,163 ) Amounts reclassified from accumulated other comprehensive income (loss) (92 ) 173 81 — 97 97 Net current period other comprehensive income (loss) 592 (253 ) 339 (2,167 ) 101 (2,066 ) Ending balance $ (5,550 ) $ (360 ) $ (5,910 ) $ (2,594 ) $ 156 $ (2,438 ) |
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] | Details about Accumulated Other Comprehensive Income (Loss) Components Amount Reclassified from Accumulated Other Comprehensive Income (Loss) Affected Line Item in the Statements of Income (Loss) Three months ended March 31, 2023 (unaudited) 2022 (unaudited) Unrealized losses on cash flow hedges $ (4 ) $ (2 ) Cost of revenues (147 ) (96 ) Research and development (4 ) (3 ) Sales and marketing (16 ) (9 ) General and administrative (171 ) (110 ) Total, before income taxes 2 (13 ) Income tax expense (benefit) (173 ) (97 ) Total, net of income taxes Unrealized gains on available-for-sale marketable securities 92 — Financial income (loss), net — — Income tax expense (benefit) 92 — Total, net of income taxes $ (81 ) $ (97 ) Total, net of income taxes |
Note 3 - Revenue Recognition (D
Note 3 - Revenue Recognition (Details Textual) $ in Thousands | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Contract with Customer, Liability, Revenue Recognized | $ 1,561 |
Note 3 - Revenue Recognition -
Note 3 - Revenue Recognition - Remaining Performance Obligation 2 (Details) $ in Thousands | Mar. 31, 2023 USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | |
Licensing, NRE and related revenues | $ 10,083 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Licensing, NRE and related revenues | 906 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Licensing, NRE and related revenues | 519 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Licensing, NRE and related revenues | $ 96 |
Note 3 - Revenue Recognition _2
Note 3 - Revenue Recognition - Remaining Performance Obligation (Details) (Parentheticals) | Mar. 31, 2023 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year |
Note 3 - Revenue Recognition _3
Note 3 - Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | ||
Revenues | $ 28,735 | $ 34,391 | |
Transferred at Point in Time [Member] | |||
Revenues | 22,635 | 27,930 | |
Transferred over Time [Member] | |||
Revenues | 6,100 | 6,461 | |
Connectivity Products [Member] | |||
Revenues | 22,197 | 25,877 | |
Smart Sensing Products [Member] | |||
Revenues | 6,538 | 8,514 | |
License [Member] | |||
Revenues | 20,721 | 22,393 | |
License [Member] | Transferred at Point in Time [Member] | |||
Revenues | 14,621 | 15,932 | |
License [Member] | Transferred over Time [Member] | |||
Revenues | 6,100 | 6,461 | |
License [Member] | Connectivity Products [Member] | |||
Revenues | 16,532 | 16,815 | |
License [Member] | Smart Sensing Products [Member] | |||
Revenues | 4,189 | 5,578 | |
Royalty [Member] | |||
Revenues | 8,014 | 11,998 | |
Royalty [Member] | Transferred at Point in Time [Member] | |||
Revenues | 8,014 | 11,998 | |
Royalty [Member] | Connectivity Products [Member] | |||
Revenues | 5,665 | 9,062 | |
Royalty [Member] | Smart Sensing Products [Member] | |||
Revenues | 2,349 | 2,936 | |
UNITED STATES | |||
Revenues | 4,441 | 6,746 | |
UNITED STATES | License [Member] | |||
Revenues | 2,791 | 4,475 | |
UNITED STATES | Royalty [Member] | |||
Revenues | 1,650 | 2,271 | |
Europe and Middle East [Member] | |||
Revenues | 3,193 | 1,102 | |
Europe and Middle East [Member] | License [Member] | |||
Revenues | 2,334 | 437 | |
Europe and Middle East [Member] | Royalty [Member] | |||
Revenues | 859 | 665 | |
Asia Pacific [Member] | |||
Revenues | [1] | 20,626 | 26,543 |
Asia Pacific [Member] | License [Member] | |||
Revenues | 15,121 | 17,481 | |
Asia Pacific [Member] | Royalty [Member] | |||
Revenues | 5,505 | 9,062 | |
Other [Member] | |||
Revenues | 475 | 0 | |
Other [Member] | License [Member] | |||
Revenues | 475 | 0 | |
Other [Member] | Royalty [Member] | |||
Revenues | $ 0 | $ 0 | |
[1]China |
Note 3 - Revenue Recognition _4
Note 3 - Revenue Recognition - Assets and Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Contract with customer liability, balance | $ 4,006 | $ 3,168 |
Trade Receivables [Member] | ||
Contract with customer asset, balance | 17,430 | 12,297 |
Accrued Revenues [Member] | Licensing and Other [Member] | ||
Contract with customer asset, balance | 9,731 | 8,695 |
Accrued Revenues [Member] | Royalty [Member] | ||
Contract with customer asset, balance | 7,846 | 10,258 |
Deferred Revenue [Member] | ||
Contract with customer liability, balance | $ 4,006 | $ 3,168 |
Note 4 - Leases -Lease Cost (De
Note 4 - Leases -Lease Cost (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Weighted average remaining lease term (years) (Year) | 4 years 10 months 6 days | |
Weighted average discount rates | 3.51% | |
Operating lease cost | $ 822 | $ 800 |
Cash payments for operating leases | $ 819 | $ 830 |
Note 4 - Leases - Maturities of
Note 4 - Leases - Maturities of Lease Liabilities (Details) $ in Thousands | Mar. 31, 2023 USD ($) |
The remainder of 2023 | $ 2,257 |
2024 | 2,589 |
2025 | 1,979 |
2026 | 970 |
2027 | 962 |
2028 and thereafter | 1,361 |
Total undiscounted cash flows | 10,118 |
Less imputed interest | 730 |
Present value of lease liabilities | $ 9,388 |
Note 5 - Marketable Securitie_2
Note 5 - Marketable Securities - Available-for-sale Marketable Securities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Marketable securities | $ 106,142 | $ 112,080 |
Corporate Bonds [Member] | ||
Available-for-sale - matures within one year, Amortized cost | 23,397 | 17,552 |
Available-for-sale - matures within one year, Gross unrealized gains | 0 | 0 |
Available-for-sale - matures within one year, Gross unrealized losses | (1,517) | (1,330) |
Available-for-sale - matures within one year, Fair value | 21,880 | 16,222 |
Available-for-sale - matures after one year through five years, Amortized cost | 88,934 | 101,355 |
Available-for-sale - matures after one year through five years, Gross unrealized gains | 25 | 38 |
Available-for-sale - matures after one year through five years, Gross unrealized losses | (4,697) | (5,535) |
Available-for-sale - matures after one year through five years, Fair value | 84,262 | 95,858 |
Debt Securities, Available-for-Sale, Amortized Cost | 112,331 | 118,907 |
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax | 25 | 38 |
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax | (6,214) | (6,865) |
Marketable securities | $ 106,142 | $ 112,080 |
Note 5 - Marketable Securitie_3
Note 5 - Marketable Securities - Summary of Gross Unrealized Losses and Fair Values on Investments (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Less than 12 months, Fair value | $ 36,115 | $ 58,706 |
Less than 12 months, Gross unrealized loss | (877) | (1,885) |
12 months or greater, Fair value | 64,211 | 48,539 |
12 months or greater, Gross unrealized loss | $ (5,337) | $ (4,980) |
Note 5 - Marketable Securitie_4
Note 5 - Marketable Securities - Summary of Gross Realized Gains and Losses from Sale of Available-for-sale Marketable Securities (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Gross realized gains from sale of available-for-sale marketable securities | $ 92 | $ 0 |
Gross realized losses from sale of available-for-sale marketable securities | $ 0 | $ 0 |
Note 6 - Fair Value Measureme_3
Note 6 - Fair Value Measurement - Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Corporate bonds | $ 106,142 | $ 112,080 |
Investments in marketable equity securities | 291 | 408 |
Foreign exchange contracts | 360 | 119 |
Foreign exchange contracts | 13 | |
Fair Value, Inputs, Level 1 [Member] | ||
Investments in marketable equity securities | 291 | 408 |
Foreign exchange contracts | 0 | 0 |
Foreign exchange contracts | 0 | |
Fair Value, Inputs, Level 2 [Member] | ||
Investments in marketable equity securities | 0 | 0 |
Foreign exchange contracts | 360 | 119 |
Foreign exchange contracts | 13 | |
Fair Value, Inputs, Level 3 [Member] | ||
Investments in marketable equity securities | 0 | 0 |
Foreign exchange contracts | 0 | 0 |
Foreign exchange contracts | 0 | |
Corporate Bonds [Member] | ||
Corporate bonds | 106,142 | 112,080 |
Corporate Bonds [Member] | Fair Value, Inputs, Level 1 [Member] | ||
Corporate bonds | 0 | 0 |
Corporate Bonds [Member] | Fair Value, Inputs, Level 2 [Member] | ||
Corporate bonds | 106,142 | 112,080 |
Corporate Bonds [Member] | Fair Value, Inputs, Level 3 [Member] | ||
Corporate bonds | $ 0 | $ 0 |
Note 7 - Intangible Assets, N_3
Note 7 - Intangible Assets, Net (Details Textual) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2018 | Dec. 31, 2022 | Dec. 31, 2019 | |
Finite-Lived Intangible Assets, Gross, Total | $ 22,661 | $ 22,661 | |||
Amortization of Intangible Assets, Total | 329 | $ 750 | |||
Immervision Technology [Member] | Operating Expense [Member] | |||||
Impairment of Intangible Assets, Finite-Lived | 3,556 | ||||
NB-IoT technologies [Member] | |||||
Finite-lived Intangible Assets Acquired | $ 2,800 | ||||
Finite Lived Intangible Assets Acquired, Balance Not Received | 600 | ||||
Finite-Lived Intangible Assets, Gross, Total | 1,961 | $ 2,200 | $ 1,961 | ||
Intangible Assets Expenditures Incurred but Not yet Paid | $ 210 | ||||
Amortization of Intangible Assets, Total | $ 239 |
Note 7 - Intangible Assets, N_4
Note 7 - Intangible Assets, Net - Schedule of Finite-lived Intangible Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2018 | ||
Total intangible assets, Gross Carrying Amount | $ 22,661 | $ 22,661 | |||
Total intangible assets, Accumulated Amortization | 13,102 | 12,425 | [1] | ||
Total intangible assets, Impairment | 3,556 | 3,556 | |||
Intangible assets, net | $ 6,003 | 6,680 | |||
Customer Relationships [Member] | Intrinsix Corp. [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 5 years 6 months | ||||
Total intangible assets, Gross Carrying Amount | $ 3,604 | 3,604 | |||
Total intangible assets, Accumulated Amortization | 1,201 | 1,037 | [1] | ||
Total intangible assets, Impairment | 0 | 0 | |||
Intangible assets, net | $ 2,403 | 2,567 | |||
Customer Relationships [Member] | Acquisition of Hillcrest Labs [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 4 years 4 months 24 days | ||||
Total intangible assets, Gross Carrying Amount | $ 3,518 | 3,518 | |||
Total intangible assets, Accumulated Amortization | 3,070 | 2,998 | [1] | ||
Total intangible assets, Impairment | 0 | 0 | |||
Intangible assets, net | $ 448 | 520 | |||
Customer Backlog [Member] | Intrinsix Corp. [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 1 year 6 months | ||||
Total intangible assets, Gross Carrying Amount | $ 421 | 421 | |||
Total intangible assets, Accumulated Amortization | 421 | 421 | [1] | ||
Total intangible assets, Impairment | 0 | 0 | |||
Intangible assets, net | $ 0 | 0 | |||
Customer Backlog [Member] | Acquisition of Hillcrest Labs [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 6 months | ||||
Total intangible assets, Gross Carrying Amount | $ 72 | 72 | |||
Total intangible assets, Accumulated Amortization | 72 | 72 | [1] | ||
Total intangible assets, Impairment | 0 | 0 | |||
Intangible assets, net | $ 0 | 0 | |||
Patents [Member] | Intrinsix Corp. [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 5 years | ||||
Total intangible assets, Gross Carrying Amount | $ 218 | 218 | |||
Total intangible assets, Accumulated Amortization | 80 | 69 | [1] | ||
Total intangible assets, Impairment | 0 | 0 | |||
Intangible assets, net | $ 138 | 149 | |||
Core Technologies [Member] | Intrinsix Corp. [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 3 years | ||||
Total intangible assets, Gross Carrying Amount | $ 3,329 | 3,329 | |||
Total intangible assets, Accumulated Amortization | 2,035 | 1,757 | [1] | ||
Total intangible assets, Impairment | 0 | 0 | |||
Intangible assets, net | $ 1,294 | 1,572 | |||
Research and Development Tools [Member] | Acquisition of Hillcrest Labs [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 7 years 6 months | ||||
Total intangible assets, Gross Carrying Amount | $ 2,475 | 2,475 | |||
Total intangible assets, Accumulated Amortization | 1,222 | 1,140 | [1] | ||
Total intangible assets, Impairment | 0 | 0 | |||
Intangible assets, net | $ 1,253 | 1,335 | |||
Research and Development Tools [Member] | Immervision [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 6 years 4 months 24 days | ||||
Total intangible assets, Gross Carrying Amount | $ 7,063 | 7,063 | |||
Total intangible assets, Accumulated Amortization | 3,507 | 3,507 | [1] | ||
Total intangible assets, Impairment | 3,556 | 3,556 | |||
Intangible assets, net | $ 0 | 0 | |||
NB-IoT technologies [Member] | |||||
Total intangible assets, Weighted Average Amortization Period (Year) | 7 years | ||||
Total intangible assets, Gross Carrying Amount | $ 1,961 | 1,961 | $ 2,200 | ||
Total intangible assets, Accumulated Amortization | 1,494 | 1,424 | [1] | ||
Total intangible assets, Impairment | [2] | 0 | 0 | ||
Intangible assets, net | $ 467 | $ 537 | [2] | ||
[1]During 2022, the Company recorded an impairment charge of $3,556 in operating expenses with respect to Immervision technology acquired in August 2019, as the Company has decided to cease the development of this product line.[2]During the first quarter of 2018, the Company entered into an agreement to acquire certain NB-IoT technologies in the amount of $2,800, of which technologies valued at $600 have not been received and have been written off during 2022. Of the $2,200, $210 has not resulted in cash outflows as of December 31, 2022. In addition, the Company participated in programs sponsored by the Hong Kong government for the support of the above investment, and as a result, the Company received during 2019 an amount of $239 related to the NB-IoT technologies, which was reduced from the gross carrying amount of intangible assets. The Company recorded the amortization cost of the NB-IoT technologies in “cost of revenues” on the Company’s consolidated statements of income (loss). |
Note 7 - Intangible Assets, N_5
Note 7 - Intangible Assets, Net - Future Amortization Expense (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Reminder of 2023 | $ 1,934 | |
2024 | 1,909 | |
2025 | 1,189 | |
2026 | 956 | |
2027 | 15 | |
Total intangible assets | $ 6,003 | $ 6,680 |
Note 8 - Geographic Informati_3
Note 8 - Geographic Information and Major Customer Data (Details Textual) | 3 Months Ended |
Mar. 31, 2023 | |
Number of Reportable Segments | 1 |
Note 8 - Geographic Informati_4
Note 8 - Geographic Information and Major Customer Data - Revenues Based On Customer Location (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | ||
Revenues | $ 28,735 | $ 34,391 | |
UNITED STATES | |||
Revenues | 4,441 | 6,746 | |
Europe and Middle East [Member] | |||
Revenues | 3,193 | 1,102 | |
Asia Pacific [Member] | |||
Revenues | [1] | 20,626 | 26,543 |
Other [Member] | |||
Revenues | 475 | 0 | |
CHINA | |||
Revenues | $ 17,763 | $ 22,971 | |
[1]China |
Note 8 - Geographic Informati_5
Note 8 - Geographic Information and Major Customer Data - Major Customers Data As Percentage of Total Revenues (Details) - Revenue from Contract with Customer Benchmark [Member] - Customer Concentration Risk [Member] | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Customer A [Member] | ||
Percentage of total revenues | 13% | 0% |
Customer B [Member] | ||
Percentage of total revenues | 12% | |
Customer C [Member] | ||
Percentage of total revenues | 11% |
Note 9 - Net Loss Per Share o_3
Note 9 - Net Loss Per Share of Common Stock (Details Textual) - shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | 1,181,119 | 853,258 |
Note 9 - Net Income (Loss) Per
Note 9 - Net Income (Loss) Per Share of Common Stock - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Net loss | $ (4,872) | $ (1,696) |
Basic (in shares) | 23,334 | 23,103 |
Effect of stock -based awards (in shares) | 0 | 0 |
Diluted weighted average common stock outstanding (in shares) | 23,334 | 23,103 |
Basic net loss per share (in dollars per share) | $ (0.21) | $ (0.07) |
Diluted net loss per share (in dollars per share) | $ (0.21) | $ (0.07) |
Note 10 - Common Stock and St_3
Note 10 - Common Stock and Stock-based Compensation Plans (Details Textual) | 3 Months Ended | 12 Months Ended | ||||||||||||
Feb. 17, 2023 | Feb. 14, 2023 USD ($) $ / shares shares | Jan. 01, 2023 USD ($) shares | Nov. 09, 2022 shares | Feb. 14, 2022 shares | Feb. 18, 2021 | Feb. 16, 2021 | Mar. 31, 2023 USD ($) shares | Dec. 31, 2021 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2022 shares | [1],[2] | |
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding Number (in shares) | 106,000 | 106,000 | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Grants in Period (in shares) | 0 | |||||||||||||
The 2002 Employee Stock Purchase Plan [Member] | ||||||||||||||
Minimum Working Hours for Eligibility of Employee Stock Purchase Plan | 20 | |||||||||||||
Restricted Stock Units (RSUs) [Member] | Vesting on February 17, 2024 [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 33.40% | |||||||||||||
Restricted Stock Units (RSUs) [Member] | Vesting on February 17, 2025 [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 33.30% | |||||||||||||
Restricted Stock Units (RSUs) [Member] | Vesting on February 17, 2026 [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 33.30% | |||||||||||||
Short-Term Executive PSUs [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded, Percentage | 30% | 20% | ||||||||||||
Short-Term Executive PSUs [Member] | Goals One [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 90% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals One [Member] | Full Vesting Based on The Achievement of 2022 License Target [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 50% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals One [Member] | Vesting Based on Achievement In Excess of 90 Percent [Member] | Maximum [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 99% | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 99% | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage | 110% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals One [Member] | Vesting Based on Achievement In Excess of 90 Percent [Member] | Minimum [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 91% | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage | 1% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals One [Member] | Increase in Eligible PSUs, Percent [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage | 2% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Two [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 25% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Two [Member] | Increase in Eligible PSUs, Percent [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage | 2% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 25% | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 90% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member] | Maximum [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 99% | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 99% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return Being at Least 90 Percent of S&P500 Index [Member] | Minimum [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 91% | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 90% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 100% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member] | Maximum [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage | 110% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Two [Member] | Vesting Based on Actual Return In Excess of 100 Percent of S&P500 Index [Member] | Minimum [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage | 1% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 25% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | Increase in Eligible PSUs, Percent [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage | 2% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | Full Vesting Based on The Achievement of Positive Shareholder Return [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 25% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 90% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member] | Maximum [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 99% | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 99% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return Being at Least 90 Percent of Russel 2000 Index [Member] | Minimum [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 91% | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 90% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Threshold, Percentage | 100% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member] | Maximum [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage | 110% | |||||||||||||
Short-Term Executive PSUs [Member] | Goals Three [Member] | Vesting Based on Actual Return In Excess of 100 Percent of Russel 2000 Index [Member] | Minimum [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Actual Performance Results, in Excess of Performance Threshold, Percentage | 1% | |||||||||||||
Short-Term Executive PSUs [Member] | Vesting on February 20, 2021 [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 33.40% | |||||||||||||
Short-Term Executive PSUs [Member] | Vesting on February 22, 2022 [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 33.30% | |||||||||||||
Short-Term Executive PSUs [Member] | Vesting on February 20, 2023 [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 33.30% | |||||||||||||
Long-term PSUs [Member] | ||||||||||||||
Share-based Payment Arrangement, Vesting Requirements, Annual Growth Rate, Percentage of Three Year Non-GAAP EPS | 10% | |||||||||||||
Share-based Payment Arrangement, Vesting Requirements, Minimum Non-GAAP EPS (in dollars per share) | $ / shares | $ 1 | |||||||||||||
Share-based Payment Arrangement, Vesting Requirements, Percentage of Non-GAAP Operating Margin | 20% | |||||||||||||
Share-based Payment Arrangement, Vesting Requirements, Percentage of Annual Growth Rate for Revenue | 10% | |||||||||||||
Share-based Payment Arrangement, Vesting Requirements, Minimum Revenue | $ | $ 180,000,000 | |||||||||||||
Share-based Payment Arrangement, Vesting Requirements, Minimum Market Capitalization for 30 Consecutive Trading Days | $ | $ 1,100,000,000 | |||||||||||||
RSUs and PSUs [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) | 141,165 | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 389,560 | |||||||||||||
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $ | $ 26,615,000 | |||||||||||||
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) | 1 year 6 months | |||||||||||||
Employees [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) | 3 years | |||||||||||||
Non-employee Director [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) | 2 years | 1 year | ||||||||||||
Non-employee Director [Member] | Restricted Stock Units (RSUs) [Member] | The2011 Stock Incentive Plan [Member] | Vesting After the First Anniversary Grant Date [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 50% | |||||||||||||
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) | 34,887 | |||||||||||||
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member] | The2011 Stock Incentive Plan [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) | 3 years | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 14,541 | 46,911 | ||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value | $ | $ 1,200 | |||||||||||||
Chief Executive Officer [Member] | Performance Share Units [Member] | The2011 Stock Incentive Plan [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 21,811 | |||||||||||||
Chief Executive Officer [Member] | Short-Term Executive PSUs [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded (in shares) | 6,543 | |||||||||||||
Chief Executive Officer [Member] | Short-Term Executive PSUs [Member] | Goals One [Member] | Increase in Eligible PSUs, Percent [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage | 3% | |||||||||||||
Chief Executive Officer [Member] | Short-Term Executive PSUs [Member] | Goals Two [Member] | Increase in Eligible PSUs, Percent [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage | 3% | |||||||||||||
Chief Executive Officer [Member] | Short-Term Executive PSUs [Member] | Goals Three [Member] | Increase in Eligible PSUs, Percent [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Conditional Increase in Shares, Percentage | 3% | |||||||||||||
Chief Executive Officer [Member] | Long-term PSUs [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 60,587 | |||||||||||||
Chief Commercial Officer [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded (in shares) | 727 | |||||||||||||
Chief Commercial Officer [Member] | Restricted Stock Units (RSUs) [Member] | The2011 Stock Incentive Plan [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) | 3 years | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 5,452 | 3,909 | ||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value | $ | $ 100 | |||||||||||||
Chief Commercial Officer [Member] | Performance Share Units [Member] | The2011 Stock Incentive Plan [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 3,635 | |||||||||||||
Chief Commercial Officer [Member] | Long-term PSUs [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 30,293 | |||||||||||||
Chief Financial Officer [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded (in shares) | 1,332 | |||||||||||||
Chief Financial Officer [Member] | Restricted Stock Units (RSUs) [Member] | The2011 Stock Incentive Plan [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 9,996 | |||||||||||||
Chief Financial Officer [Member] | Performance Share Units [Member] | The2011 Stock Incentive Plan [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 6,664 | |||||||||||||
Chief Financial Officer [Member] | Long-term PSUs [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 30,293 | |||||||||||||
Chief Operating Officer [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Addtional Shares Issuable, Performance Goals Exceeded (in shares) | 1,090 | |||||||||||||
Chief Operating Officer [Member] | Restricted Stock Units (RSUs) [Member] | The2011 Stock Incentive Plan [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 8,179 | |||||||||||||
Chief Operating Officer [Member] | Performance Share Units [Member] | The2011 Stock Incentive Plan [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 5,452 | |||||||||||||
Chief Operating Officer [Member] | Long-term PSUs [Member] | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 30,293 | |||||||||||||
Share-Based Payment Arrangement, Employee [Member] | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding Number (in shares) | 0 | |||||||||||||
[1]Represent options granted to non-employee directors of the Company only. As of December 31, 2022, there were no outstanding or exercisable SAR units left and no outstanding or exercisable options granted to employees left.[2]The SAR units are convertible for a maximum number of shares of the Company’s common stock equal to 75% of the SAR units subject to the grant. |
Note 10 - Common Stock and St_4
Note 10 - Common Stock and Stock-based Compensation Plans - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Mar. 31, 2023 | Dec. 31, 2022 | |||
Outstanding, Number of shares (in shares) | [1],[2] | 106,000 | ||
Outstanding, Weighted average exercise price (in dollars per share) | $ 20.24 | |||
Outstanding, Weighted average remaining contractual term (Year) | 1 year 9 months 18 days | 2 years | ||
Outstanding, Aggregated intrinsic value | $ 1,080 | $ 609 | ||
Outstanding, Number of shares (in shares) | 106,000 | 106,000 | [1],[2] | |
Outstanding, Weighted average exercise price (in dollars per share) | $ 20.24 | $ 20.24 | ||
Exercisable, Number of shares (in shares) | [2] | 106,000 | ||
Exercisable, Weighted average exercise price (in dollars per share) | $ 20.24 | |||
Exercisable, Weighted average remaining contractual term (Year) | 1 year 9 months 18 days | |||
Exercisable, Aggregated intrinsic value | $ 1,080 | |||
[1]Represent options granted to non-employee directors of the Company only. As of December 31, 2022, there were no outstanding or exercisable SAR units left and no outstanding or exercisable options granted to employees left.[2]The SAR units are convertible for a maximum number of shares of the Company’s common stock equal to 75% of the SAR units subject to the grant. |
Note 10 - Common Stock and St_5
Note 10 - Common Stock and Stock-based Compensation Plans - Summary of Restricted Stock Units Activity (Details) - RSUs and PSUs [Member] | 3 Months Ended |
Mar. 31, 2023 $ / shares shares | |
Unvested, number (in shares) | shares | 879,277 |
Unvested, weighted average fair value (in dollars per share) | $ / shares | $ 37.57 |
Granted, number (in shares) | shares | 389,560 |
Granted, weighted average fair value (in dollars per share) | $ / shares | $ 23.56 |
Vested, number (in shares) | shares | (141,165) |
Vested, weighted average fair value (in dollars per share) | $ / shares | $ 40.02 |
Forfeited or expired, number (in shares) | shares | (52,553) |
Forfeited or expired, weighted average fair value (in dollars per share) | $ / shares | $ 34.58 |
Unvested, number (in shares) | shares | 1,075,119 |
Unvested, weighted average fair value (in dollars per share) | $ / shares | $ 32.32 |
Note 10 - Common Stock and St_6
Note 10 - Common Stock and Stock-based Compensation Plans - Equity-based Compensation Expense Included in Interim Condensed Consolidated Statements of Income (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Total equity-based compensation expense | $ 3,859 | $ 3,389 |
Cost of Revenues [Member] | ||
Total equity-based compensation expense | 404 | 339 |
Research and Development, Net [Member] | ||
Total equity-based compensation expense | 2,173 | 1,995 |
Sales and Marketing [Member] | ||
Total equity-based compensation expense | 393 | 333 |
General and Administrative [Member] | ||
Total equity-based compensation expense | $ 889 | $ 722 |
Note 10 - Common Stock and St_7
Note 10 - Common Stock and Stock-based Compensation Plans - Valuation Assumptions (Details) - The 2002 Employee Stock Purchase Plan [Member] - Purchase Rights [Member] | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Expected dividend yield | 0% | |
Expected volatility, Minimum | 45% | |
Expected volatility | 38% | |
Risk-free interest rate, Minimum | 4.80% | |
Risk-free interest rate | 0.50% | |
Contractual term of up to (Month) | 6 months | 6 months |
Note 11 - Derivatives and Hed_3
Note 11 - Derivatives and Hedging Activities (Details Textual) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Derivative, Notional Amount | $ 9,700 | $ 12,200 |
Derivative, Gain (Loss) on Derivative, Net | $ 171 | $ 110 |
Note 11 - Derivatives and Hed_4
Note 11 - Derivatives and Hedging Activities - Effective Portion of the Gains and Losses on Derivative Instruments Designated (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Foreign exchange forward contracts | $ 13 | ||
Foreign exchange contracts | $ 360 | 119 | |
Derivatives designated as cash flow hedging instruments | (425) | $ 2 | |
Cash Flow Hedging [Member] | |||
Derivative Asset, Total | 0 | 13 | |
Derivative Liability, Total | 360 | 119 | |
Derivatives designated as cash flow hedging instruments | (425) | 2 | |
Cash Flow Hedging [Member] | Foreign Exchange Option [Member] | |||
Foreign exchange contracts | 128 | 23 | |
Derivatives designated as cash flow hedging instruments | (105) | 0 | |
Cash Flow Hedging [Member] | Foreign Exchange Forward [Member] | |||
Foreign exchange forward contracts | 0 | 13 | |
Foreign exchange contracts | 232 | $ 96 | |
Derivatives designated as cash flow hedging instruments | $ (320) | $ 2 |
Note 11 - Derivatives and Hed_5
Note 11 - Derivatives and Hedging Activities - Net (Gains) Losses Reclassified from Accumulated Other Comprehensive Loss (Details) - Derivatives Designated as Cash Flow Hedging Instruments [Member] - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total | $ 171 | $ 110 |
Foreign Exchange Option Contracts [Member] | ||
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total | 0 | 0 |
Foreign Exchange Forward Contracts [Member] | ||
Gain (loss) reclassified from accumulated OCI into income, Effective portion, Net, Total | $ 171 | $ 110 |
Note 12 - Accumulated Other C_3
Note 12 - Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Balances of Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Balance | $ 258,871 | $ 276,732 |
Balance | 259,870 | 278,079 |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] | ||
Balance | (6,142) | (427) |
Other comprehensive income (loss) before reclassifications | 684 | (2,167) |
Amounts reclassified from accumulated other comprehensive income (loss) | (92) | 0 |
Net current period other comprehensive income (loss) | 592 | (2,167) |
Balance | (5,550) | (2,594) |
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] | ||
Balance | (107) | 55 |
Other comprehensive income (loss) before reclassifications | (426) | 4 |
Amounts reclassified from accumulated other comprehensive income (loss) | 173 | 97 |
Net current period other comprehensive income (loss) | (253) | 101 |
Balance | (360) | 156 |
AOCI Attributable to Parent [Member] | ||
Balance | (6,249) | (372) |
Other comprehensive income (loss) before reclassifications | 258 | (2,163) |
Amounts reclassified from accumulated other comprehensive income (loss) | 81 | 97 |
Net current period other comprehensive income (loss) | 339 | (2,066) |
Balance | $ (5,910) | $ (2,438) |
Note 12 - Accumulated Other C_4
Note 12 - Accumulated Other Comprehensive Income (Loss) - Reclassifications Out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cost of revenues | $ 5,315 | $ 6,404 |
Research and development | (20,791) | (20,210) |
Sales and marketing | (3,045) | (2,923) |
General and administrative | (4,048) | (3,636) |
Total, before income taxes | (3,455) | (381) |
Financial income (loss), net | 1,455 | 282 |
Income tax expense | 1,417 | 1,315 |
Net loss | (4,872) | (1,696) |
Income tax expense (benefit) | 1,417 | 1,315 |
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Cash Flow Hedges [Member] | ||
Cost of revenues | (4) | (2) |
Research and development | (16) | (9) |
Sales and marketing | (171) | (110) |
General and administrative | 2 | (13) |
Total, before income taxes | (173) | (97) |
Income tax expense | 0 | 0 |
Net loss | 92 | 0 |
Income tax expense (benefit) | 0 | 0 |
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Available-for-sale Marketable Securities [Member] | ||
Financial income (loss), net | 92 | 0 |
Income tax expense | (81) | (97) |
Income tax expense (benefit) | $ (81) | $ (97) |
Note 13 - Share Repurchase Pr_2
Note 13 - Share Repurchase Program (Details Textual) - shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Treasury Stock, Shares, Acquired (in shares) | 0 | 0 |
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased (in shares) | 278,799 |
Note 14 - Subsequent Event (Det
Note 14 - Subsequent Event (Details Textual) - VisiSonics [Member] - Subsequent Event [Member] $ in Millions | 1 Months Ended |
May 30, 2023 USD ($) | |
Business Combination, Price of Acquisition, Expected | $ 3.6 |
Business Combination, Price of Acquisition, Expected Additional Payment Per Founder | $ 0.1 |